263 related articles for article (PubMed ID: 15190972)
1. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E
Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
[TBL] [Abstract][Full Text] [Related]
2. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
[TBL] [Abstract][Full Text] [Related]
3. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets during endotoxic shock.
Chin A; Radhakrishnan J; Fornell L; John E
J Pediatr Surg; 2002 Mar; 37(3):482-7. PubMed ID: 11877672
[TBL] [Abstract][Full Text] [Related]
4. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock.
Somell A; Weitzberg E; Suneson A; Sollevi A; Hjelmqvist H
Acta Physiol (Oxf); 2007 Aug; 190(4):291-302. PubMed ID: 17498196
[TBL] [Abstract][Full Text] [Related]
5. Cardiac effects of endothelin receptor antagonism in endotoxemic pigs.
Konrad D; Haney M; Johansson G; Wanecek M; Weitzberg E; Oldner A
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H988-96. PubMed ID: 17400719
[TBL] [Abstract][Full Text] [Related]
6. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
7. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E
Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
[TBL] [Abstract][Full Text] [Related]
8. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury.
Persson BP; Rossi P; Weitzberg E; Oldner A
Shock; 2009 Oct; 32(4):427-34. PubMed ID: 19197226
[TBL] [Abstract][Full Text] [Related]
9. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
Chin A; Radhakrishnan J; Fornell L; John E
J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
[TBL] [Abstract][Full Text] [Related]
10. Effects of the endothelin receptor antagonist bosentan on cardiac performance during porcine endotoxin shock.
Wanecek M; Weitzberg E; Alving K; Rudehill A; Oldner A
Acta Anaesthesiol Scand; 2001 Nov; 45(10):1262-70. PubMed ID: 11736680
[TBL] [Abstract][Full Text] [Related]
11. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
Hedelin P; Kylhammar D; Rådegran G
Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
[TBL] [Abstract][Full Text] [Related]
12. The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock.
Fenhammar J; Andersson A; Frithiof R; Forestier J; Weitzberg E; Sollevi A; Hjelmqvist H
Acta Anaesthesiol Scand; 2008 Nov; 52(10):1385-93. PubMed ID: 19025532
[TBL] [Abstract][Full Text] [Related]
13. Effects of endothelin receptor antagonism on acute lung injury induced by chlorine gas.
Wang J; Oldner A; Winskog C; Edston E; Walther SM
Crit Care Med; 2006 Jun; 34(6):1731-7. PubMed ID: 16625121
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.
Torre-Amione G; Young JB; Durand J; Bozkurt B; Mann DL; Kobrin I; Pratt CM
Circulation; 2001 Feb; 103(7):973-80. PubMed ID: 11181472
[TBL] [Abstract][Full Text] [Related]
15. Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock.
Andersson A; Fenhammar J; Frithiof R; Weitzberg E; Sollevi A; Hjelmqvist H
J Surg Res; 2008 Sep; 149(1):138-47. PubMed ID: 18639249
[TBL] [Abstract][Full Text] [Related]
16. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
Lundgren J; Kylhammar D; Hedelin P; Rådegran G
Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 blockade corrects mesenteric hypoperfusion in a porcine low cardiac output model.
Burgener D; Laesser M; Treggiari-Venzi M; Oi Y; Jolliet P; Strasser S; Hadengue A; Aneman A
Crit Care Med; 2001 Aug; 29(8):1615-20. PubMed ID: 11505140
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding protein (HBP/CAP37) - a link to endothelin-1 in endotoxemia-induced pulmonary oedema?
Persson BP; Halldorsdottir H; Lindbom L; Rossi P; Herwald H; Weitzberg E; Oldner A
Acta Anaesthesiol Scand; 2014 May; 58(5):549-59. PubMed ID: 24611481
[TBL] [Abstract][Full Text] [Related]
19. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
[TBL] [Abstract][Full Text] [Related]
20. Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction.
Clozel M; Qiu C; Qiu CS; Hess P; Clozel JP
J Am Coll Cardiol; 2002 Jan; 39(1):142-7. PubMed ID: 11755300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
